Chronic cough, defined as a cough lasting more than eight weeks, presents a prevalent yet complex issue in clinical practice. Despite its seeming simplicity, its multifaceted nature poses a challenge to healthcare professionals. This article seeks to shed light on this often mystifying condition and provide a comprehensive approach to its management.
Chronic cough can be attributed to a plethora of causes, including but not limited to postnasal drip syndrome, gastroesophageal reflux disease (GERD), and asthma. It is crucial to conduct a thorough patient history and physical examination to identify potential causes. Additional diagnostic tests may be necessary to confirm the diagnosis.
Treatment should be individualized based on the identified cause. For instance, GERD-related coughs may require proton pump inhibitors, while coughs due to asthma might need inhaled corticosteroids. It is essential to monitor patients closely and adjust the treatment plan as necessary.
Refractory chronic cough, or cough that remains unresponsive to treatment, requires further evaluation. This could include high-resolution computed tomography, bronchoscopy, or referral to a specialist. Neuromodulatory therapies can be considered in cases of refractory chronic cough.
Patients must understand their condition and the importance of adhering to the treatment plan. Educating patients about potential triggers and how to avoid them can also be beneficial. Regular follow-up appointments should be scheduled to monitor progress and make necessary adjustments to the treatment plan.
Chronic cough, while common, is a complex condition that requires a comprehensive and individualized approach. By understanding the underlying causes, implementing tailored treatment plans, addressing refractory cases, and emphasizing patient education, healthcare professionals can effectively manage chronic cough in clinical practice.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation